首页 > 最新文献

Arkhiv patologii最新文献

英文 中文
[Breast granular cell tumor]. [乳腺颗粒细胞瘤]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/patol20248604148
S A Povzun, N Yu Novitskaya

The report of the biopsy diagnosis of the granular cell tumor with rare localization in the breast is given. Currently, the tumor is considered a neoplasm of neuroectodermal origin. Differential diagnostic criteria for the tumor are positive expression in cytoplasm of protein S-100, absence of expression of epithelial antigens, histiocytic antigens, oncoproteins, estrogens and progesterone receptors, PAS-positive reaction of intracellular granules. With ultrasound examination and mammography, a tumor always initially assessed as cancer or calcification.

本文报告了乳腺罕见定位颗粒细胞瘤的活检诊断结果。目前,该肿瘤被认为是神经外胚层起源的肿瘤。该肿瘤的鉴别诊断标准是细胞质中蛋白 S-100 阳性表达,无上皮抗原、组织细胞抗原、肿瘤蛋白、雌激素和孕激素受体表达,细胞内颗粒的 PAS 阳性反应。通过超声波检查和乳房 X 线照相术,肿瘤最初总是被评估为癌症或钙化。
{"title":"[Breast granular cell tumor].","authors":"S A Povzun, N Yu Novitskaya","doi":"10.17116/patol20248604148","DOIUrl":"https://doi.org/10.17116/patol20248604148","url":null,"abstract":"<p><p>The report of the biopsy diagnosis of the granular cell tumor with rare localization in the breast is given. Currently, the tumor is considered a neoplasm of neuroectodermal origin. Differential diagnostic criteria for the tumor are positive expression in cytoplasm of protein S-100, absence of expression of epithelial antigens, histiocytic antigens, oncoproteins, estrogens and progesterone receptors, PAS-positive reaction of intracellular granules. With ultrasound examination and mammography, a tumor always initially assessed as cancer or calcification.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141787158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role of immunohistochemical examination in the differential diagnosis of atypical tumors and carcinomas of parathyroid glands]. [免疫组化检查在甲状旁腺非典型肿瘤和癌的鉴别诊断中的作用]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/patol2024860415
E I Kim, A A Lavreniuk, L S Urusova, A K Eremkina, A R Elfimova, N G Mokrysheva

Differential diagnosis of atypical parathyroid tumors (APT) and parathyroid carcinomas (PC) is important in determining further management and prognosis. Morphologic diagnosis is sometimes difficult, in which case it is supplemented by immunohistochemical (IHC) examination.

Objective: Studying the role of IHC analysis in the differential diagnosis of APT and PC.

Material and methods: The study included 44 patients with morphologic diagnosis of the APT established after surgical treatment for primary hyperparathyroidism on the basis of Endocrinology Research Centre during 2018-2023. All cases underwent IHC examination with evaluation of CD31/CD34 and parathormone (PTH) expression for identification of vascular invasion, Ki-67, parafibromin.

Results: According to the results of IHC analysis in 8/44 patients (18.2%) the diagnosis of APT was revised in favor of the PC: in 7 of them vascular invasion was detected; in 1 patient the additional series of slices in the surrounding fatty tissue revealed foci of tumor growth, confirmed by positive reaction with antibodies to PTH. According to IHC results, the material was divided into 2 groups: APT and PC. There were no differences in clinical and morphological characteristics, Ki-67% level and parafibromin expression between the groups.

Conclusion: Assessment of clinical and laboratory-instrumental data at the preoperative stage does not allow differentiating APT from PC. In case of APT diagnosis and detection of suspicious morphological features, it is necessary to perform IHC examination to exclude PC.

非典型甲状旁腺瘤(APT)和甲状旁腺癌(PC)的鉴别诊断对于确定进一步的治疗和预后非常重要。形态学诊断有时比较困难,在这种情况下,可以通过免疫组化(IHC)检查进行补充:研究 IHC 分析在 APT 和 PC 鉴别诊断中的作用:研究纳入2018-2023年期间基于内分泌学研究中心的44例原发性甲状旁腺功能亢进症手术治疗后形态学诊断为APT的患者。所有病例均接受了IHC检查,评估CD31/CD34和副甲状腺激素(PTH)表达,以鉴别血管侵犯、Ki-67、副纤维蛋白:根据 IHC 分析结果,8/44 例患者(18.2%)的 APT 诊断被改判为 PC:其中 7 例检测到血管侵犯;1 例患者在周围脂肪组织的附加切片系列中发现肿瘤生长灶,经 PTH 抗体阳性反应证实。根据 IHC 结果,材料被分为两组:APT 组和 PC 组。各组间的临床和形态特征、Ki-67%水平和副纤维蛋白表达均无差异:结论:术前阶段的临床和实验室仪器数据评估无法区分 APT 和 PC。在确诊 APT 并发现可疑形态特征时,有必要进行 IHC 检查以排除 PC。
{"title":"[The role of immunohistochemical examination in the differential diagnosis of atypical tumors and carcinomas of parathyroid glands].","authors":"E I Kim, A A Lavreniuk, L S Urusova, A K Eremkina, A R Elfimova, N G Mokrysheva","doi":"10.17116/patol2024860415","DOIUrl":"https://doi.org/10.17116/patol2024860415","url":null,"abstract":"<p><p>Differential diagnosis of atypical parathyroid tumors (APT) and parathyroid carcinomas (PC) is important in determining further management and prognosis. Morphologic diagnosis is sometimes difficult, in which case it is supplemented by immunohistochemical (IHC) examination.</p><p><strong>Objective: </strong>Studying the role of IHC analysis in the differential diagnosis of APT and PC.</p><p><strong>Material and methods: </strong>The study included 44 patients with morphologic diagnosis of the APT established after surgical treatment for primary hyperparathyroidism on the basis of Endocrinology Research Centre during 2018-2023. All cases underwent IHC examination with evaluation of CD31/CD34 and parathormone (PTH) expression for identification of vascular invasion, Ki-67, parafibromin.</p><p><strong>Results: </strong>According to the results of IHC analysis in 8/44 patients (18.2%) the diagnosis of APT was revised in favor of the PC: in 7 of them vascular invasion was detected; in 1 patient the additional series of slices in the surrounding fatty tissue revealed foci of tumor growth, confirmed by positive reaction with antibodies to PTH. According to IHC results, the material was divided into 2 groups: APT and PC. There were no differences in clinical and morphological characteristics, Ki-67% level and parafibromin expression between the groups.</p><p><strong>Conclusion: </strong>Assessment of clinical and laboratory-instrumental data at the preoperative stage does not allow differentiating APT from PC. In case of APT diagnosis and detection of suspicious morphological features, it is necessary to perform IHC examination to exclude PC.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141787162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical and laboratory parameters and pathomorphological features of the lungs in patients who have had COVID-19 viral pneumonia]. [COVID-19病毒性肺炎患者肺部的临床和实验室参数及病理形态特征]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/patol20248601127
A S Kontorshchikov, L M Mikhaleva, M A Sharafetdinova, O A Vasyukova, I S Kozlov, R A Vandysheva, L V Kakturskiy

Post-Covid syndrome is characterized by general somatic manifestations, changes in the psycho-emotional sphere, cognitive disorders, disorders of the cardiovascular, respiratory systems and excretory function. However, there is little information in the literature about the mechanisms of thanatogenesis in patients who have had COVID-19. An analysis of clinical and laboratory parameters and pathomorphological changes was carried out in 9 autopsy cases of patients who had previously suffered a new coronavirus infection (COVID-19). The age of the deceased ranged from 80 to 96 years. At the time of hospitalization, the concentration of IgG varied from 32.61 to 1013.5 RLU, IgM - from 0.29 to 16.98 U/ml. The period from clinical diagnosis to death ranged from 12 to 46 days, and the time from clinical recovery (negative polymerase chain reaction) to death ranged from 2 to 30 days. In all cases, unresolved viral pneumonia and diffuse alveolar damage (exudative-proliferative phase) were diagnosed.

后科维德综合征的特点是全身表现、心理情绪变化、认知障碍、心血管、呼吸系统和排泄功能紊乱。然而,文献中关于 COVID-19 患者比兴机制的信息很少。研究人员对 9 例曾感染新型冠状病毒(COVID-19)的尸检病例进行了临床和实验室参数以及病理形态学变化分析。死者的年龄从 80 岁到 96 岁不等。住院时,IgG 浓度从 32.61 到 1013.5 RLU 不等,IgM - 从 0.29 到 16.98 U/ml 不等。从临床诊断到死亡的时间从 12 天到 46 天不等,从临床康复(聚合酶链反应阴性)到死亡的时间从 2 天到 30 天不等。在所有病例中,均诊断出未治愈的病毒性肺炎和弥漫性肺泡损伤(渗出-增生期)。
{"title":"[Clinical and laboratory parameters and pathomorphological features of the lungs in patients who have had COVID-19 viral pneumonia].","authors":"A S Kontorshchikov, L M Mikhaleva, M A Sharafetdinova, O A Vasyukova, I S Kozlov, R A Vandysheva, L V Kakturskiy","doi":"10.17116/patol20248601127","DOIUrl":"10.17116/patol20248601127","url":null,"abstract":"<p><p>Post-Covid syndrome is characterized by general somatic manifestations, changes in the psycho-emotional sphere, cognitive disorders, disorders of the cardiovascular, respiratory systems and excretory function. However, there is little information in the literature about the mechanisms of thanatogenesis in patients who have had COVID-19. An analysis of clinical and laboratory parameters and pathomorphological changes was carried out in 9 autopsy cases of patients who had previously suffered a new coronavirus infection (COVID-19). The age of the deceased ranged from 80 to 96 years. At the time of hospitalization, the concentration of IgG varied from 32.61 to 1013.5 RLU, IgM - from 0.29 to 16.98 U/ml. The period from clinical diagnosis to death ranged from 12 to 46 days, and the time from clinical recovery (negative polymerase chain reaction) to death ranged from 2 to 30 days. In all cases, unresolved viral pneumonia and diffuse alveolar damage (exudative-proliferative phase) were diagnosed.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139691091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Papillary renal neoplasm with reverse polarity]. [极性相反的乳头状肾肿瘤]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/patol20248601144
E A Dubova, V N Vysotskaya

Papillary renal neoplasm with reverse polarity is a rare subtype of papillary renal cell tumors with unique morphology, specific molecular features and good prognosis. The article presents literature data and describes our own observation of a papillary kidney tumor with reverse nuclear polarity in a 73-year-old patient. The difficulties of preoperative diagnosis of a tumor are shown, histological and immunohistochemical criteria for diagnosis and differential diagnosis of this tumor with other kidney tumors are presented. This rare case is of interest for both pathologists and clinicians.

具有反向极性的乳头状肾肿瘤是乳头状肾细胞瘤的一种罕见亚型,具有独特的形态学、特定的分子特征和良好的预后。文章介绍了文献数据,并描述了我们自己在一名 73 岁患者身上观察到的具有反向核极性的乳头状肾肿瘤。文章介绍了肿瘤术前诊断的困难、组织学和免疫组化诊断标准以及该肿瘤与其他肾脏肿瘤的鉴别诊断。病理学家和临床医生对这一罕见病例都很感兴趣。
{"title":"[Papillary renal neoplasm with reverse polarity].","authors":"E A Dubova, V N Vysotskaya","doi":"10.17116/patol20248601144","DOIUrl":"10.17116/patol20248601144","url":null,"abstract":"<p><p>Papillary renal neoplasm with reverse polarity is a rare subtype of papillary renal cell tumors with unique morphology, specific molecular features and good prognosis. The article presents literature data and describes our own observation of a papillary kidney tumor with reverse nuclear polarity in a 73-year-old patient. The difficulties of preoperative diagnosis of a tumor are shown, histological and immunohistochemical criteria for diagnosis and differential diagnosis of this tumor with other kidney tumors are presented. This rare case is of interest for both pathologists and clinicians.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139691098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Exosomes' role in intercellular interactions in different variants of lung injury in fatal cases of COVID-19]. [外泌体在 COVID-19 死亡病例肺损伤不同变体中的细胞间相互作用中的作用]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/patol20248602122
E A Zarubin, E A Kogan, N V Zharkov, A M Avdalyan, D N Procenko

Background: Extracellular vesicles are surrounded by a phospholipid bilayer, carrying various active biomolecules and participating in many physiological and pathological processes, including infectious ones.

Objective: To research the role of exosomes in intercellular interactions in the pathogenesis of various types of lung damage in fatal cases of COVID-19.

Material and methods: We conducted a clinical and morphological analysis of 118 fatal cases caused by coronavirus infection in Moscow. We selected 32 cases with morphological signs of various types of lung lesions for immunohistochemical reaction (IHC) with antibodies against tetraspanin proteins (CD63, CD81), which are involved in the assembly of exosomes, as well as with antibodies against viral proteins: nucleocapsid and spike protein. We determined the main producing cells of extracellular vesicles and cells containing viral proteins, carried out their comparison and quantitative analysis.

Results: IHC reaction with antibodies against CD63 showed cytoplasmic granular uniform and subapical staining of cells, as well as granular extracellular staining. We determined similar staining using antibodies against viral proteins. Extracellular vesicles were found in the same cells as viral proteins. The main producing cells of vesicles and cells containing viral proteins were found to be macrophages, type II pneumocytes, and endothelial cells.

Conclusion: Taking into account the results of the literature, the localization of viral proteins and extracellular vesicles in the same cells indicates the key role of vesicles in the pathogenesis of various forms of lung damage by the SARS-CoV-2 virus, in the dissemination of the pathogen in the organism, which leads to interaction with the adaptive immune system and the formation of immunity.

背景:细胞外囊泡由磷脂双分子层包围,携带各种活性生物大分子,参与许多生理和病理过程,包括感染过程:研究COVID-19致死病例中外泌体在各种肺损伤发病机制中细胞间相互作用的作用:我们对莫斯科118例冠状病毒感染致死病例进行了临床和形态学分析。我们选取了 32 例具有各种肺部病变形态学特征的病例,用参与外泌体组装的四跨蛋白(CD63、CD81)抗体以及病毒蛋白(核头蛋白和尖峰蛋白)抗体进行免疫组化反应(IHC)。我们确定了细胞外囊泡的主要产生细胞和含有病毒蛋白的细胞,并对它们进行了比较和定量分析:结果:使用 CD63 抗体进行的 IHC 反应显示,细胞出现细胞质颗粒状均匀染色和近尖端染色,以及颗粒状细胞外染色。我们使用针对病毒蛋白的抗体确定了类似的染色。在与病毒蛋白相同的细胞中发现了细胞外囊泡。我们发现,产生囊泡和含有病毒蛋白的细胞主要是巨噬细胞、II型肺细胞和内皮细胞:考虑到文献研究的结果,病毒蛋白和细胞外囊泡在同一细胞中的定位表明,囊泡在 SARS-CoV-2 病毒造成的各种肺损伤的发病机制中起着关键作用,在病原体在机体内的传播中起着关键作用,这导致了与适应性免疫系统的相互作用和免疫力的形成。
{"title":"[Exosomes' role in intercellular interactions in different variants of lung injury in fatal cases of COVID-19].","authors":"E A Zarubin, E A Kogan, N V Zharkov, A M Avdalyan, D N Procenko","doi":"10.17116/patol20248602122","DOIUrl":"https://doi.org/10.17116/patol20248602122","url":null,"abstract":"<p><strong>Background: </strong>Extracellular vesicles are surrounded by a phospholipid bilayer, carrying various active biomolecules and participating in many physiological and pathological processes, including infectious ones.</p><p><strong>Objective: </strong>To research the role of exosomes in intercellular interactions in the pathogenesis of various types of lung damage in fatal cases of COVID-19.</p><p><strong>Material and methods: </strong>We conducted a clinical and morphological analysis of 118 fatal cases caused by coronavirus infection in Moscow. We selected 32 cases with morphological signs of various types of lung lesions for immunohistochemical reaction (IHC) with antibodies against tetraspanin proteins (CD63, CD81), which are involved in the assembly of exosomes, as well as with antibodies against viral proteins: nucleocapsid and spike protein. We determined the main producing cells of extracellular vesicles and cells containing viral proteins, carried out their comparison and quantitative analysis.</p><p><strong>Results: </strong>IHC reaction with antibodies against CD63 showed cytoplasmic granular uniform and subapical staining of cells, as well as granular extracellular staining. We determined similar staining using antibodies against viral proteins. Extracellular vesicles were found in the same cells as viral proteins. The main producing cells of vesicles and cells containing viral proteins were found to be macrophages, type II pneumocytes, and endothelial cells.</p><p><strong>Conclusion: </strong>Taking into account the results of the literature, the localization of viral proteins and extracellular vesicles in the same cells indicates the key role of vesicles in the pathogenesis of various forms of lung damage by the SARS-CoV-2 virus, in the dissemination of the pathogen in the organism, which leads to interaction with the adaptive immune system and the formation of immunity.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pyloric gland adenoma - a rare tumor of the upper gastrointestinal tract with a high risk of malignancy]. [幽门腺腺瘤--一种罕见的上消化道肿瘤,恶变风险高]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/patol20248602130
A S Tertychnyy, N V Pachuashvili, D D Protsenko, S T Avraamova, D P Nagornaya, P V Pavlov, A P Kiryukhin, A A Fedorenko

Background: Pyloric gland adenomas (PGA) are rare neoplasms of the gastrointestinal tract. According to the literature, these lesions may be underdiagnosed, and their true frequency of occurrence is underestimated.

Objective: Clinical and morphological analysis of eight PGA cases of the upper gastrointestinal tract.

Material and methods: The study included 8 cases of detection of PGA. In 7 out of 8 cases, the tumor was diagnosed by examining endoscopic biopsies, in 1 case, PGA was an accidental finding in the surgical material after proximal gastric resection.

Results: 6 out of 8 patients were female, the median age was 65 years (minimum 36 years and maximum 78 years). In 6 cases, PDA was localized in the stomach, in 1 - in the esophagus and in 1 - in the duodenum The size of the tumors ranged from 0.6 cm to 7.5 cm. 4 out of 6 stomach tumors appeared on the background of confirmed autoimmune gastritis, 1 - on the background of lymphocytic gastritis. 4 tumors were found in the body of the stomach, 1 - in the cardia, 1 - in the bottom of the stomach. In 2 out of 8 cases, there were signs of malignancy of the tumor with the transition to a highly differentiated adenocarcinoma. According to the results of the IHC study, the absence of a p53 mutation was noted in these cases.

Conclusion: PGA should be considered as neoplasms with a high risk of transformation into invasive adenocarcinoma. Increasing the recognition of PGA among pathologists and further understanding of the molecular mechanisms involved in their neoplastic transformation will improve the diagnosis and treatment of this pathology.

背景:幽门腺腺瘤(PGA)是一种罕见的胃肠道肿瘤。根据文献报道,这些病变可能诊断不足,其真实发生率被低估:对8例上消化道PGA进行临床和形态学分析:研究纳入了 8 例 PGA 病例。8例中有7例是通过内镜活检确诊的,1例是在近端胃切除术后的手术材料中意外发现的PGA:8名患者中有6名女性,中位年龄为65岁(最小36岁,最大78岁)。肿瘤大小从 0.6 厘米到 7.5 厘米不等。6 个胃肿瘤中有 4 个出现在确诊的自身免疫性胃炎的背景下,1 个出现在淋巴细胞性胃炎的背景下。4 个肿瘤位于胃体,1 个位于贲门,1 个位于胃底部。在 8 个病例中,有 2 个病例的肿瘤有恶变迹象,并向高分化腺癌转化。根据 IHC 研究结果,这些病例均未发现 p53 基因突变:结论:PGA 应被视为具有向浸润性腺癌转化高风险的肿瘤。提高病理学家对 PGA 的认识,进一步了解其肿瘤转化的分子机制,将有助于改善该病症的诊断和治疗。
{"title":"[Pyloric gland adenoma - a rare tumor of the upper gastrointestinal tract with a high risk of malignancy].","authors":"A S Tertychnyy, N V Pachuashvili, D D Protsenko, S T Avraamova, D P Nagornaya, P V Pavlov, A P Kiryukhin, A A Fedorenko","doi":"10.17116/patol20248602130","DOIUrl":"https://doi.org/10.17116/patol20248602130","url":null,"abstract":"<p><strong>Background: </strong>Pyloric gland adenomas (PGA) are rare neoplasms of the gastrointestinal tract. According to the literature, these lesions may be underdiagnosed, and their true frequency of occurrence is underestimated.</p><p><strong>Objective: </strong>Clinical and morphological analysis of eight PGA cases of the upper gastrointestinal tract.</p><p><strong>Material and methods: </strong>The study included 8 cases of detection of PGA. In 7 out of 8 cases, the tumor was diagnosed by examining endoscopic biopsies, in 1 case, PGA was an accidental finding in the surgical material after proximal gastric resection.</p><p><strong>Results: </strong>6 out of 8 patients were female, the median age was 65 years (minimum 36 years and maximum 78 years). In 6 cases, PDA was localized in the stomach, in 1 - in the esophagus and in 1 - in the duodenum The size of the tumors ranged from 0.6 cm to 7.5 cm. 4 out of 6 stomach tumors appeared on the background of confirmed autoimmune gastritis, 1 - on the background of lymphocytic gastritis. 4 tumors were found in the body of the stomach, 1 - in the cardia, 1 - in the bottom of the stomach. In 2 out of 8 cases, there were signs of malignancy of the tumor with the transition to a highly differentiated adenocarcinoma. According to the results of the IHC study, the absence of a p53 mutation was noted in these cases.</p><p><strong>Conclusion: </strong>PGA should be considered as neoplasms with a high risk of transformation into invasive adenocarcinoma. Increasing the recognition of PGA among pathologists and further understanding of the molecular mechanisms involved in their neoplastic transformation will improve the diagnosis and treatment of this pathology.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140847855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pathology of the kidneys in malignant tumors of various localizations and antitumor therapy]. [不同部位恶性肿瘤的肾脏病理学和抗肿瘤治疗]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/patol20248603159
T A Garkusha, E S Stolyarevich, V A Khorzhevskii, S V Ivliev, M A Firsov

Non-tumorlesions of the kidneys in malignant neoplasms are very diverse. They can alter the results of chemotherapy and lead to death in the long term. In this regard, the related discipline of onconephrology has increasingly begun to be identified, which emphasizes the importance of diagnosing non-tumor kidney lesions in this category of patients. This review is devoted to the classification, diagnosis, course, prevention and treatment of non-tumor kidney lesions in patients with malignant neoplasms. There are four groups of lesions: mechanical damage; nephropathy due to anticancer therapy; paraneoplastic nephropathy; lesions associated with metabolic disorders. Kidney lesions in patients with malignant neoplasms are characterized by a variable course. In some cases, acute renal failure develops. Others are characterized by an asymptomatic course with an outcome in nephrosclerosis. Timely diagnosis and treatment of kidney lesions in malignant neoplasms can improve the quality of life and prognosis of patients with malignant neoplasms.

恶性肿瘤的肾脏非肿瘤性病变多种多样。它们会改变化疗的效果,并在长期内导致死亡。在这方面,相关的肾脏病学学科已开始被越来越多地确认,这强调了诊断这类患者肾脏非肿瘤性病变的重要性。本综述主要介绍恶性肿瘤患者肾脏非肿瘤性病变的分类、诊断、病程、预防和治疗。病变分为四类:机械性损伤;抗癌治疗引起的肾病;副肿瘤性肾病;与代谢紊乱有关的病变。恶性肿瘤患者肾脏病变的特点是病程多变。有些病例会出现急性肾衰竭。另一些病例的特点是病程无症状,最终导致肾硬化。及时诊断和治疗恶性肿瘤的肾脏病变可以改善恶性肿瘤患者的生活质量和预后。
{"title":"[Pathology of the kidneys in malignant tumors of various localizations and antitumor therapy].","authors":"T A Garkusha, E S Stolyarevich, V A Khorzhevskii, S V Ivliev, M A Firsov","doi":"10.17116/patol20248603159","DOIUrl":"https://doi.org/10.17116/patol20248603159","url":null,"abstract":"<p><p>Non-tumorlesions of the kidneys in malignant neoplasms are very diverse. They can alter the results of chemotherapy and lead to death in the long term. In this regard, the related discipline of onconephrology has increasingly begun to be identified, which emphasizes the importance of diagnosing non-tumor kidney lesions in this category of patients. This review is devoted to the classification, diagnosis, course, prevention and treatment of non-tumor kidney lesions in patients with malignant neoplasms. There are four groups of lesions: mechanical damage; nephropathy due to anticancer therapy; paraneoplastic nephropathy; lesions associated with metabolic disorders. Kidney lesions in patients with malignant neoplasms are characterized by a variable course. In some cases, acute renal failure develops. Others are characterized by an asymptomatic course with an outcome in nephrosclerosis. Timely diagnosis and treatment of kidney lesions in malignant neoplasms can improve the quality of life and prognosis of patients with malignant neoplasms.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expression of transferrin receptor 1 and β1-integrins correlates with estrogen receptor status and immune infiltration in breast cancer]. [转铁蛋白受体 1 和 β1-integrins 的表达与雌激素受体状态和乳腺癌的免疫浸润相关]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/patol20248604123
S V Chulkova, E N Sholokhova, I V Poddubnaya, I A Gladilina, A V Egorova, I S Stilidi

Cancer cells can aberrantly express various markers, including transferrin receptor 1 (CD71) and β1-integrin molecules. Their role in invasion, migration and metastasis has been demonstrated. Determination of their expression in breast cancer (BC) may be an important point to characterize the clinical course of the tumor and prognosis of the disease.

Objective: To study of transferrin receptor 1 (CD71) expression by primary breast cancer cells in correlation with tumor cell phenotype.

Material and methods: Determination of BC phenotype: immunohistochemical staining method (immunofluorescence). Antibodies to ER (estrogen receptors), KL-1 (pancytokeratin), CD71 (transferrin receptor), CD29 (β1-integrins). CD45, CD3, CD4, CD8, CD20 infiltration was also evaluated. ZEISS microscope (AXIOSKOP; Germany), method of G.J. Hammerling et al. Statistical processing: IBM-SPSS Statistics v.21.

Results: 63% of BC cases had CD71+ phenotype. CD71-mosaic tumors were observed in 14.4%. β1-integrin expression was monomorphic in 51.6% of cases and mosaic in 38.7%. 85% of ER-positive tumors were CD71-positive with a monomorphic type of reaction; p=0.014. Among ER-negative tumors, CD71-negative reactions were 2-fold more frequent and the monomorphic type was less frequent. ER-positive tumors were CD29-positive in 73%; p=0.031. 45.5% of ER+ tumors were CD29-monomorphic. Among ER-negative tumors, the frequency of CD29-monomorphic tumors was 55%. Significant infiltration by CD3+ cells was predominant in CD71-positive tumors; p=0.016. In the CD29-monomorphic phenotype, CD45+ infiltration was 31.3%, and in the mosaic phenotype, 67.1%.

Conclusion: BC aberrantly expresses transferrin receptors, β1-integrins. CD71 expression is associated with ER expression. ER-positive tumors are often monomorphic for CD71. Prominent CD3+ infiltration was present in CD71+ tumors. Expression of β1-integrins correlated with ER+ status and weak immune infiltration.

癌细胞可异常表达各种标记物,包括转铁蛋白受体 1(CD71)和β1-整合素分子。它们在侵袭、迁移和转移中的作用已得到证实。乳腺癌(BC)中转铁蛋白受体 1(CD71)和β1-整合素分子表达的确定可能是描述肿瘤临床过程和疾病预后的重要依据:研究原发性乳腺癌细胞转铁蛋白受体 1(CD71)的表达与肿瘤细胞表型的相关性:乳腺癌表型的确定:免疫组化染色法(免疫荧光)。ER(雌激素受体)、KL-1(泛型角蛋白)、CD71(转铁蛋白受体)、CD29(β1-整合素)抗体。还评估了 CD45、CD3、CD4、CD8、CD20 的浸润情况。蔡司显微镜(AXIOSKOP;德国),G.J. Hammerling 等人的方法。 统计处理:统计处理:IBM-SPSS Statistics v.21:63%的 BC 病例具有 CD71+ 表型。14.4%的病例出现了 CD71 镶嵌型肿瘤。51.6%的病例中β1-整合素表达为单形,38.7%为镶嵌型。85%的ER阳性肿瘤的CD71阳性反应为单形反应;P=0.014。在ER阴性肿瘤中,CD71阴性反应的发生率高出2倍,而单形反应的发生率较低。73%的ER阳性肿瘤呈CD29阳性;P=0.031。45.5%的ER+肿瘤呈CD29单形性。在ER阴性肿瘤中,CD29单形肿瘤的发生率为55%。CD3+ 细胞的显著浸润在 CD71 阳性肿瘤中占主导地位;P=0.016。在 CD29 单形表型中,CD45+浸润占 31.3%,在镶嵌表型中占 67.1%:结论:BC异常表达转铁蛋白受体和β1-整合素。CD71的表达与ER的表达有关。ER阳性肿瘤的CD71通常为单形。CD71+ 肿瘤中存在明显的 CD3+ 浸润。β1-整合素的表达与ER+状态和弱免疫浸润相关。
{"title":"[Expression of transferrin receptor 1 and β1-integrins correlates with estrogen receptor status and immune infiltration in breast cancer].","authors":"S V Chulkova, E N Sholokhova, I V Poddubnaya, I A Gladilina, A V Egorova, I S Stilidi","doi":"10.17116/patol20248604123","DOIUrl":"https://doi.org/10.17116/patol20248604123","url":null,"abstract":"<p><p>Cancer cells can aberrantly express various markers, including transferrin receptor 1 (CD71) and <i>β</i>1-integrin molecules. Their role in invasion, migration and metastasis has been demonstrated. Determination of their expression in breast cancer (BC) may be an important point to characterize the clinical course of the tumor and prognosis of the disease.</p><p><strong>Objective: </strong>To study of transferrin receptor 1 (CD71) expression by primary breast cancer cells in correlation with tumor cell phenotype.</p><p><strong>Material and methods: </strong>Determination of BC phenotype: immunohistochemical staining method (immunofluorescence). Antibodies to ER (estrogen receptors), KL-1 (pancytokeratin), CD71 (transferrin receptor), CD29 (<i>β</i>1-integrins). CD45, CD3, CD4, CD8, CD20 infiltration was also evaluated. ZEISS microscope (AXIOSKOP; Germany), method of G.J. Hammerling et al. Statistical processing: IBM-SPSS Statistics v.21.</p><p><strong>Results: </strong>63% of BC cases had CD71+ phenotype. CD71-mosaic tumors were observed in 14.4%. <i>β</i>1-integrin expression was monomorphic in 51.6% of cases and mosaic in 38.7%. 85% of ER-positive tumors were CD71-positive with a monomorphic type of reaction; <i>p</i>=0.014. Among ER-negative tumors, CD71-negative reactions were 2-fold more frequent and the monomorphic type was less frequent. ER-positive tumors were CD29-positive in 73%; <i>p</i>=0.031. 45.5% of ER+ tumors were CD29-monomorphic. Among ER-negative tumors, the frequency of CD29-monomorphic tumors was 55%. Significant infiltration by CD3+ cells was predominant in CD71-positive tumors; <i>p</i>=0.016. In the CD29-monomorphic phenotype, CD45+ infiltration was 31.3%, and in the mosaic phenotype, 67.1%.</p><p><strong>Conclusion: </strong>BC aberrantly expresses transferrin receptors, <i>β</i>1-integrins. CD71 expression is associated with ER expression. ER-positive tumors are often monomorphic for CD71. Prominent CD3+ infiltration was present in CD71+ tumors. Expression of <i>β</i>1-integrins correlated with ER+ status and weak immune infiltration.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141787081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Amplifiation of the c-MYC gene in acinar prostate adenocarcinoma. Morphogenic comparisons]. [前列腺尖锐湿疣中 c-MYC 基因的扩增。形态比较]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/patol20248603130
V A Khorzhevskii, E V Alymova, A K Kirichenko, S V Gappoev, Yu V Anzhiganova

Objective: The purpose of this work was to evaluate c-MYC gene amplification in the substrate of prostate acinar adenocarcinoma at various Gleason scores and various stages of the disease, taking into account the morphological characteristics of the tumor.

Material and methods: The number of cases in the study was 82, including the control group - 12 cases. Morphological assessment included: determination of the total Gleason score, grading group, assessment of lymphovascular/perineural invasion, and architectural characteristics of the tumor. Gene amplification was assessed by FISH using the c-MYC (8q24)/SE8 probe.

Results: In all cases of the study group, amplification of the c-MYC gene was detected in the tumor, with a significant difference from the control group (p<0.05). When assessing cases with 4-6 fold copies of the gene, significant differences were established between patients with stages II and III of the disease and stage IV (10.0 and 13.5 versus 30.0) (p<0.05). Cluster amplification of the c-MYC gene was detected with equal frequency in groups of patients with stages III and IV of the disease, while in stage II of the disease, the event almost did not occur (p<0.05). A significant increase in the level of c-MYC gene amplification was found in groups with advanced stages of the disease (p<0.02). Non-cluster amplification significantly distinguishes T4M0 and T4M1 stage patients from the rest with a significant increase in the score (p<0.05). In the metastatic stage of the disease, there was an increase c-MYC gene amplification compared to the non-metastatic stage (p<0.02). The copy number of the c-MYC gene was significantly higher in cases with perineural and lymphovascular invasion, as well as in cases of cribriform tumor organization (p<0.05).

Conclusion: Amplification of the c-MYC gene in prostate tumor cells is associated with advanced stages of the disease (T4M0 and T4M1) with an increase in the copy number of the gene during the metastatic stage of the process. It was found that increased amplification of the c-MYC gene distinguishes groups of patients whose tumors exhibit perineural and lymphovascular invasion, as well as a cribriform pattern of tumor organization.

目的:本研究的目的是在考虑肿瘤形态学特征的基础上,评估不同Gleason评分和不同病期的前列腺尖腺癌基质中的c-MYC基因扩增情况:研究病例数为 82 例,其中对照组 12 例。形态学评估包括:确定格里森总分、分级组别、淋巴管/神经周围侵犯评估以及肿瘤的结构特征。基因扩增通过使用 c-MYC (8q24)/SE8 探针进行 FISH 评估:结果:在研究组的所有病例中,肿瘤中都检测到了 c-MYC 基因的扩增,与对照组相比差异显著(pppppp结论:前列腺肿瘤细胞中 c-MYC 基因的扩增与疾病的晚期(T4M0 和 T4M1)有关,在转移阶段,该基因的拷贝数会增加。研究发现,c-MYC 基因扩增的增加可将肿瘤表现为神经周围和淋巴管侵犯以及楔形肿瘤组织模式的患者群体区分开来。
{"title":"[Amplifiation of the c-MYC gene in acinar prostate adenocarcinoma. Morphogenic comparisons].","authors":"V A Khorzhevskii, E V Alymova, A K Kirichenko, S V Gappoev, Yu V Anzhiganova","doi":"10.17116/patol20248603130","DOIUrl":"https://doi.org/10.17116/patol20248603130","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this work was to evaluate <i>c-MYC</i> gene amplification in the substrate of prostate acinar adenocarcinoma at various Gleason scores and various stages of the disease, taking into account the morphological characteristics of the tumor.</p><p><strong>Material and methods: </strong>The number of cases in the study was 82, including the control group - 12 cases. Morphological assessment included: determination of the total Gleason score, grading group, assessment of lymphovascular/perineural invasion, and architectural characteristics of the tumor. Gene amplification was assessed by FISH using the c-MYC (8q24)/SE8 probe.</p><p><strong>Results: </strong>In all cases of the study group, amplification of the c-MYC gene was detected in the tumor, with a significant difference from the control group (<i>p</i><0.05). When assessing cases with 4-6 fold copies of the gene, significant differences were established between patients with stages II and III of the disease and stage IV (10.0 and 13.5 versus 30.0) (<i>p</i><0.05). Cluster amplification of the c-MYC gene was detected with equal frequency in groups of patients with stages III and IV of the disease, while in stage II of the disease, the event almost did not occur (<i>p</i><0.05). A significant increase in the level of c-MYC gene amplification was found in groups with advanced stages of the disease (<i>p</i><0.02). Non-cluster amplification significantly distinguishes T4M0 and T4M1 stage patients from the rest with a significant increase in the score (<i>p</i><0.05). In the metastatic stage of the disease, there was an increase c-MYC gene amplification compared to the non-metastatic stage (<i>p</i><0.02). The copy number of the c-MYC gene was significantly higher in cases with perineural and lymphovascular invasion, as well as in cases of cribriform tumor organization (<i>p</i><0.05).</p><p><strong>Conclusion: </strong>Amplification of the <i>c-MYC</i> gene in prostate tumor cells is associated with advanced stages of the disease (T4M0 and T4M1) with an increase in the copy number of the gene during the metastatic stage of the process. It was found that increased amplification of the <i>c-MYC</i> gene distinguishes groups of patients whose tumors exhibit perineural and lymphovascular invasion, as well as a cribriform pattern of tumor organization.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Potter sequence in a newborn with polycystic kidney disease]. [多囊肾新生儿的波特序列]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/patol20248601149
N S Averkin, T V Pryazhentseva, A P Stolyarov, E A Kharitonov, I V Rybakova

A rare clinical case of a newborn boy with a diagnosed Potter sequence is presented. The diagnosis was made based on polycystic dysplasia of the kidneys, cysts in the liver, hypoplasia of the lungs and characteristic external signs due to critical oligohydramnios. The child's parents were closely related, which suggested an autosomal recessive form of the disease. The newborn lived for 15 hours, after which the death, developed as a result of respiratory failure, was ascertained.

本报告介绍了一个罕见的临床病例,该病例是一名被诊断为波特序列的新生男婴。诊断依据是肾脏多囊发育不良、肝脏囊肿、肺发育不全以及临界少尿症导致的特征性外部体征。孩子的父母关系密切,这表明该病是一种常染色体隐性遗传病。新生儿存活了 15 个小时,之后因呼吸衰竭死亡。
{"title":"[Potter sequence in a newborn with polycystic kidney disease].","authors":"N S Averkin, T V Pryazhentseva, A P Stolyarov, E A Kharitonov, I V Rybakova","doi":"10.17116/patol20248601149","DOIUrl":"10.17116/patol20248601149","url":null,"abstract":"<p><p>A rare clinical case of a newborn boy with a diagnosed Potter sequence is presented. The diagnosis was made based on polycystic dysplasia of the kidneys, cysts in the liver, hypoplasia of the lungs and characteristic external signs due to critical oligohydramnios. The child's parents were closely related, which suggested an autosomal recessive form of the disease. The newborn lived for 15 hours, after which the death, developed as a result of respiratory failure, was ascertained.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139691100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arkhiv patologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1